Back

Rationale and design of the CADENCE trial: evaluating sotatercept in Cpc-PH secondary to HFpEF

1 September 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Pharmacotherapy for heart failure (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Alessia Urbinati

New York (United States of America)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mr E. Boada Lincango (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Doctor B. Muk (Budapest, HU)
Abstract
Presentation thumbnail
Doctor P. Amornritvanich (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Pharmacotherapy for heart failure (1)

The Event

Event poster

ESC Congress 2025

1 September 2025 10:00 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources